mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.3 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.3 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.3 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |